Association of Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio with Calcification and Cardiovascular Markers in Chronic Kidney Disease

S. Roumeliotis*, I.E. Neofytou, C. Maassen, P. Lux, K. Kantartzi, E. Papachristou, L.J. Schurgers, V. Liakopoulos

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We aimed to investigate the association between Red Blood Cell Distribution Width (RDW) and Neutrophil-to-Lymphocyte Ratio (NLR), simple, rapidly assessed markers from the complete blood count with vascular calcification (VC)/stiffness and cardiovascular disease (CVD) in chronic kidney disease (CKD). Dephosphorylated, uncarboxylated matrix Gla-protein (dp-ucMGP), and central/peripheral hemodynamics' parameters were measured in 158 CKD patients, including Hemodialysis and Peritoneal Dialysis. Spearman's rho analysis showed that RDW correlated with C-reactive protein (CRP) (r = 0.29, p < 0.001), dp-ucMGP (r = 0.43, p = < 0.0001), central diastolic blood pressure (DBP) (r = -0.19, p = 0.02), and albuminuria (r = -0.17, p = 0.03). NLR correlated with the duration of CVD (r = 0.32, p < 0.001), CRP (r = 0.27, p = 0.01), dp-ucMGP (r = 0.43, p < 0.0001), central DBP (r = -0.32, p < 0.0001) and eGFR (r = -0.25, p = 0.04). In multiple regression models, circulating dp-ucMGP was an independent predictor of RDW (beta = 0.001, p = 0.001) and NLR (beta = 0.002, p = 0.002). In CKD patients, RDW and NLR are associated with traditional and novel markers of VC and CVD.
Original languageEnglish
Article number303
Number of pages15
JournalMetabolites
Volume13
Issue number2
DOIs
Publication statusPublished - 1 Feb 2023

Keywords

  • cardiovascular disease
  • chronic kidney disease
  • dephosphorylatyed uncarboxylated Matrix Gla Protein
  • endothelial dysfunction
  • inflammation
  • red blood cell distribution width
  • Neutrophil-to-lymphocyte ratio
  • vascular calcification
  • CORONARY-ARTERY CALCIFICATION
  • PREDICTING ALL-CAUSE
  • VASCULAR CALCIFICATION
  • PROGNOSTIC MARKER
  • CAUSE MORTALITY
  • HEART-FAILURE
  • INFLAMMATION
  • BIOMARKERS
  • PARAMETERS
  • RISK

Cite this